Stay updated on Amivantamab & Lazertinib in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Amivantamab & Lazertinib in NSCLC Clinical Trial page.
Latest updates to the Amivantamab & Lazertinib in NSCLC Clinical Trial page
- Check6 days agoChange DetectedThe website has been updated with new additions including a revision to v2.14.1 and estimated last update dates, while the previous version v2.14.0 and several October 2024 entries have been removed.SummaryDifference0.7%
- Check13 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.2%
- Check20 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoNo Change Detected
- Check42 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check49 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for those interested in joining the study, along with a reference to the Contacts and Locations section.SummaryDifference2%
- Check64 days agoChange DetectedSeveral key URLs related to genetics, lung cancer, and clinical trial data have been removed, indicating a potential shift in focus or resource availability on the website.SummaryDifference3%
- Check71 days agoChange DetectedNew resources related to genetics and lung cancer have been added, including links to MedlinePlus and DailyMed, which may be of particular interest for health information and drug details.SummaryDifference0.3%
Stay in the know with updates to Amivantamab & Lazertinib in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab & Lazertinib in NSCLC Clinical Trial page.